Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03682796
Title Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Triphase Research and Development III Corp.
Indications

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

Therapies

TRPH-222

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.